查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1293975

全球伤口生物製品市场：按产品类型、伤口类型和最终用户 - 预测 2023-2030

Wound Biologics Market by Product (Biologic Skin Substitutes, Topical Agents), Wound Type (Burns, Surgical and Traumatic Wounds, Ulcers), End-User - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球伤口生物製剂市场规模预计将大幅成长，到2023年将达到498,096万美元，复合年增长率为9.82%，到2030年将达到97,0412万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球伤口生物製剂市场至关重要。透过检验业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 伤口生物製剂的全球市场规模与预测为何？

2.在预测期内，COVID-19对全球伤口生物製剂市场的阻碍因素与影响为何？

3. 在预测期内，全球伤口生物製品市场需要投资哪些产品/细分市场/应用/领域？

4. 全球伤口生物製剂市场的竞争策略为何？

5. 全球伤口生物製剂市场的技术趋势和法律规范是什么？

6. 全球伤口生物製剂市场主要供应商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入全球伤口生物製剂市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 政府关于伤口护理的配合措施
      • 烧伤和交通事故增加
      • 全球老年人口不断增加
    • 抑制因素
      • 昂贵的伤口护理费用
    • 机会
      • 创新伤口护理生物製剂简介
      • 外科手术中对生物工程皮肤替代品的潜在需求
    • 任务
      • 缺乏训练有素的医生和污染相关的併发症
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章伤口生物製品市场：依产品类型

  • 生物皮肤替代品
    • 无细胞动物衍生产品
    • 生物合成产品
    • 人类供体组织衍生产品
  • 外用製剂

第7章伤口生物製品市场：依伤口类型

  • 烧伤
  • 手术伤口及外伤伤口
  • 溃疡
    • 糖尿病足溃疡
    • 褥疮
    • 静脉溃疡

第8章伤口生物製剂市场：依最终使用者分类

  • 门诊手术中心
  • 烧伤中心
  • 医院
  • 伤口诊所

第9章美洲伤口生物製剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太伤口生物製剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲伤口生物製剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-0315DDADCE4C

The Global Wound Biologics Market is forecasted to grow significantly, with a projected USD 4,980.96 million in 2023 at a CAGR of 9.82% and expected to reach a staggering USD 9,704.12 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Wound Biologics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Wound Biologics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Biologic Skin Substitutes and Topical Agents. The Biologic Skin Substitutes is further studied across Acellular Animal-derived Products, Biosynthetic Products, and Human Donor Tissue-derived Products. The Biologic Skin Substitutes commanded largest market share of 43.53% in 2022, followed by Topical Agents.

Based on Wound Type, market is studied across Burns, Surgical and Traumatic Wounds, and Ulcers. The Ulcers is further studied across Diabetic Foot Ulcers, Pressure Ulcers, and Venous Ulcers. The Surgical and Traumatic Wounds commanded largest market share of 42.71% in 2022, followed by Ulcers.

Based on End-User, market is studied across Ambulatory Surgery Centers, Burn Centers, Hospitals, and Wound Clinics. The Hospitals commanded largest market share of 39.22% in 2022, followed by Ambulatory Surgery Centers.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 42.03% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Wound Biologics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Wound Biologics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Wound Biologics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Wound Biologics Market?

4. What is the competitive strategic window for opportunities in the Global Wound Biologics Market?

5. What are the technology trends and regulatory frameworks in the Global Wound Biologics Market?

6. What is the market share of the leading vendors in the Global Wound Biologics Market?

7. What modes and strategic moves are considered suitable for entering the Global Wound Biologics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Wound Biologics Market, by Product, 2022 vs 2030
  • 4.3. Wound Biologics Market, by Wound Type, 2022 vs 2030
  • 4.4. Wound Biologics Market, by End-User, 2022 vs 2030
  • 4.5. Wound Biologics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government Initiatives Regarding Wound Care Treatment
      • 5.1.1.2. Rising Incidences of Burn Injuries and Road Accidents
      • 5.1.1.3. Increasing Geriatric Population Globally
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Wound Treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of Innovative Wound Care Biologics
      • 5.1.3.2. Potential Need for Bioengineered Skin Substitutes in Surgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Trained Physicians and Complications Associated with the Contamination
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Wound Biologics Market, by Product

  • 6.1. Introduction
  • 6.2. Biologic Skin Substitutes
    • 6.2.1. Acellular Animal-derived Products
    • 6.2.2. Biosynthetic Products
    • 6.2.3. Human Donor Tissue-derived Products
  • 6.3. Topical Agents

7. Wound Biologics Market, by Wound Type

  • 7.1. Introduction
  • 7.2. Burns
  • 7.3. Surgical and Traumatic Wounds
  • 7.4. Ulcers
    • 7.4.1. Diabetic Foot Ulcers
    • 7.4.2. Pressure Ulcers
    • 7.4.3. Venous Ulcers

8. Wound Biologics Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Burn Centers
  • 8.4. Hospitals
  • 8.5. Wound Clinics

9. Americas Wound Biologics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Wound Biologics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Wound Biologics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

1. 3M Company

2. Anika Therapeutics, Inc

3. Avita Medical, Inc.

4. Bioventus Inc.

5. Blaine Labs Inc.

6. ConvaTec Group PLC

7. Cytori Therapeutics Inc.

8. Integra Lifesciences Holdings Corporation

9. Kerecis hf

10. Marine Polymer Technologies, Inc.

11. MediWound Ltd.

12. MIMEDX GROUP, INC.

13. Molnlycke Health Care AB

14. Nuo Therapeutics, Inc.

15. Organogenesis Inc.

16. Polymedics Innovations GmbH

17. Royal Biologics, Inc.

18. Skye Biologics Holdings, LLC

19. Smith & Nephew PLC

20. Stability Biologics

21. Stryker Corporation

22. Surgilogix, LLC

23. Tides Medical

24. Vericel Corporation

25. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. WOUND BIOLOGICS MARKET RESEARCH PROCESS
  • FIGURE 2. WOUND BIOLOGICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. WOUND BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2022 VS 2030 (%)
  • FIGURE 6. WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. WOUND BIOLOGICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. WOUND BIOLOGICS MARKET DYNAMICS
  • FIGURE 9. WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. WOUND BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. WOUND BIOLOGICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. WOUND BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 6. WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. WOUND BIOLOGICS MARKET SIZE, BY ACELLULAR ANIMAL-DERIVED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. WOUND BIOLOGICS MARKET SIZE, BY BIOSYNTHETIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. WOUND BIOLOGICS MARKET SIZE, BY HUMAN DONOR TISSUE-DERIVED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. WOUND BIOLOGICS MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. WOUND BIOLOGICS MARKET SIZE, BY BURNS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. WOUND BIOLOGICS MARKET SIZE, BY SURGICAL AND TRAUMATIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 15. WOUND BIOLOGICS MARKET SIZE, BY ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. WOUND BIOLOGICS MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. WOUND BIOLOGICS MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. WOUND BIOLOGICS MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. WOUND BIOLOGICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. WOUND BIOLOGICS MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. WOUND BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. WOUND BIOLOGICS MARKET SIZE, BY WOUND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. WOUND BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 234. WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 235. WOUND BIOLOGICS MARKET LICENSE & PRICING